How Healthspan Intelligence Works
Healthspan Intelligence combines established clinical risk factors, functional measurements, and healthy-aging evidence to identify strengths, weak links, and practical priorities.
This page explains how the framework is structured, how information is weighted, how uncertainty is handled, and where the current System has important limitations.
What This Methodology Covers
The goal is transparency. Visitors should be able to understand not only what the System reports, but why it reports it.
How healthspan is divided into clinical risk, physical reserve, and intrinsic capacity.
How individual domains are evaluated without blending everything into one overall score.
How measured data, estimates, questionnaires, and missing information are treated differently.
Why potentially important medical findings are separated from ordinary healthspan scoring.
How established evidence is kept separate from promising or experimental longevity ideas.
What the System has not yet validated and what its scores should—and should not—mean.
Healthspan Is Evaluated Across Separate Domains
The System does not attempt to measure one universal “health age.” Instead, it evaluates several areas that contribute to long-term health, function, and independence.
Clinical Risk & Organ Health
These domains focus on established factors associated with disease burden and future clinical risk.
What the Body Can Actually Do
Direct performance measures are emphasized whenever practical rather than relying only on reported exercise habits.
Capacity Beyond Laboratory Results
Healthy aging also depends on cognitive, sensory, restorative, and psychosocial capacities that cannot be described by blood tests alone.
Nutrition, smoking or nicotine exposure, alcohol, physical activity, sedentary behavior, medications, existing diagnoses, and other context can influence several domains. They are not automatically treated as separate healthspan scores.
Each Domain Is Scored on Its Own
Healthspan Intelligence uses rule-based scoring within individual domains. Scores help organize information and show relative strengths and weaknesses, but they are not clinical diagnoses or externally validated biological-age measures.
Clinical, laboratory, functional, or contextual information enters the relevant domain.
Each variable has one primary scoring owner to reduce double counting.
Rules translate the available evidence into a 0–100 domain score.
The score is displayed as Strong, Good, Opportunity, Priority, or Major Priority.
No Overall Longevity Score
Domain scores are not averaged into one headline number. A strong result elsewhere should not conceal an important weakness.
One Primary Owner
A variable is assigned to one main scoring domain. Other domains may use it as context, but it should not be repeatedly penalized.
Capacity Over Behavior
When direct performance data are available, they generally take priority over behavior proxies. Measured VO₂max, for example, is more informative than exercise minutes alone.
Weak Links Stay Visible
Important weaknesses can limit the interpretation of a domain even when other measurements within that domain are favorable.
A lower band means that the domain deserves more attention. It does not by itself mean that a person has a disease. Clinical safety findings are handled separately from these visualization bands.
A Score and Its Confidence Are Not the Same Thing
Healthspan Intelligence separates the estimated status of a domain from how confident the System can be in that estimate. This prevents missing information from being mistaken for poor health.
Domain Score
Describes what the available measurements suggest about the healthspan status of that domain.
Confidence
Describes how complete and how reliable the supporting information is.
Measurement Quality Matters
Not every input provides the same level of information. Direct clinical and performance measurements generally receive greater confidence than estimates or questionnaires.
Missing = Unhealthy
A person should not receive a worse health score simply because a laboratory test, fitness measurement, or other input has not been entered.
Missing = Less Certain
The domain can still be estimated from the available information, but its confidence is reduced until stronger or more complete data are added.
Clinical Safety Is Kept Separate From Healthspan Scoring
Healthspan scores are designed to organize strengths and weaknesses. They are not a substitute for recognizing findings that may warrant medical attention.
Domain Score
Describes relative reserve, control, or opportunity within a healthspan domain.
Safety Flag
Identifies a potentially important finding that may deserve medical evaluation independent of the healthspan score.
Identify measurements or combinations that cross a clinically relevant safety threshold.
Keep the finding outside ordinary healthspan scoring so favorable results cannot hide it.
Consider symptoms, existing diagnoses, treatment status, persistence, and other relevant context.
Recommend routine, prompt, or urgent professional evaluation when the finding warrants it.
Examples of Separate Clinical Pathways
These findings are handled differently from an ordinary lower healthspan score.
Severity and symptoms can change the recommended level of follow-up.
Screening-range findings are distinguished from an established diagnosis and may require confirmation.
Very elevated values can carry risks that should not be treated as ordinary metabolic optimization.
Kidney interpretation considers filtration, albuminuria, persistence, and clinical context rather than one isolated number.
Fracture history and appropriate bone-density interpretation can trigger a separate clinical pathway.
Symptoms can change the meaning and urgency of otherwise similar numerical results.
Stronger Evidence Gets More Influence
Healthspan Intelligence distinguishes established clinical and human evidence from promising but less certain longevity ideas. Evidence strength affects how recommendations are prioritized, not whether an idea sounds innovative or popular.
Established Evidence
Supported by major clinical guidelines, strong human outcome evidence, or well-validated functional measurements.
Internal priority weight: 1.00Strong Supporting Evidence
Supported by substantial human evidence, but with greater uncertainty, narrower applicability, or less direct outcome evidence.
Internal priority weight: 0.80Emerging Evidence
Biologically plausible or supported by limited human studies, observational evidence, or early intervention trials.
Internal priority weight: 0.50Experimental or Speculative
Primarily mechanistic, preclinical, preliminary, or insufficiently demonstrated in humans for routine healthspan recommendations.
Internal priority weight: 0.20Where the Framework Draws Its Evidence
Different domains require different types of authoritative reference material. The System prioritizes established clinical guidance and validated functional reference data whenever they are available.
Blood pressure guidance, dyslipidemia recommendations, ApoB, Lp(a), coronary calcium, and contemporary cardiovascular-risk frameworks.
Established diabetes and prediabetes thresholds, glycemic interpretation, triglyceride risk, and treatment-aware metabolic context.
KDIGO-based interpretation using filtration, albuminuria, persistence, and clinical context rather than isolated eGFR alone.
Validated exercise-testing reference datasets and age- and sex-aware interpretation of measured aerobic capacity.
Population reference data and established functional-performance frameworks for grip strength, chair rise, mobility, and fall risk.
Bone-density interpretation, fracture-risk principles, screening guidance, sleep, cognition, nutrition, and functional-aging research.
Recommendations Are Prioritized — Not Simply Listed
The System considers several factors together so a long list of minor longevity ideas does not compete with a more important and better-supported health issue.
Potentially important medical findings or safety issues are addressed before ordinary longevity optimization.
High-evidence actions such as cardiovascular-risk control, physical activity, fitness, strength, sleep, tobacco avoidance, and diet quality.
Lower-priority refinements are considered only after more important risks and foundational behaviors have been addressed.
What the System Can — and Cannot — Claim
Healthspan Intelligence combines established evidence with a custom decision-support architecture. Transparency requires separating the validated components from the parts of the framework that still need independent testing.
What Has External Support
What Still Requires Validation
The System Does Not Claim To:
Important Sources of Uncertainty
Even validated measurements have limitations when applied outside the population, setting, or measurement method in which they were studied.
Memory, misunderstanding, or inaccurate measurement can affect manually entered values and questionnaires.
Wearables, home devices, body-composition systems, and fitness estimates can differ in accuracy and reproducibility.
Normative datasets may not represent every age, ancestry, disease state, training background, or population equally well.
Laboratory values, blood pressure, sleep, weight, and performance can vary over time and with measurement conditions.
Clinical guidelines and healthy-aging evidence evolve. Thresholds, recommendations, and interpretation require periodic review.
No assessment captures every biological, environmental, genetic, psychological, and social determinant of health.
The “What If…?” Simulator Is Exploratory
The simulator recalculates the System using hypothetical input changes. It demonstrates how the scoring framework responds to those changes. It does not predict that the intervention will produce that exact biological response, nor does it estimate years of life gained.
Trends Are Most Useful Under Comparable Conditions
Repeated measurements are easier to interpret when similar methods, devices, laboratory conditions, and testing procedures are used. A change in measurement method can sometimes look like a change in health.
What Should Happen Next
The current System should be viewed as a structured educational framework. Further development should test whether its architecture performs reliably outside the development environment.
Independent clinical and scientific review of thresholds, logic, omissions, safety, and interpretation.
Test clarity, usability, misunderstanding, completion rates, and decision usefulness in real users.
Examine whether similar inputs produce stable and reproducible domain interpretations.
Study whether domain scores and changes meaningfully relate to established health, function, and clinical outcomes over time.
Evidence Behind the Current Methodology
Healthspan Intelligence draws on clinical guidelines, professional consensus statements, population reference datasets, and peer-reviewed research. The sources below represent major frameworks used in the current version; they are not an exhaustive bibliography.
Risk Factors & Prevention
Contemporary lipid-risk assessment, LDL-C management, ApoB, lipoprotein(a), coronary artery calcium, and cardiovascular-risk refinement.
View official guideline · 2026 ↗ (opens in a new tab)Diagnostic thresholds, prediabetes, glycemic interpretation, cardiovascular risk, and treatment-aware metabolic context.
View Standards of Care · 2026 ↗ (opens in a new tab)CKD Classification & Risk
Interpretation of eGFR, albuminuria, CKD classification, persistence, risk stratification, and clinical context.
View official KDIGO guideline · 2024 ↗ (opens in a new tab)Physical Reserve
Age- and sex-aware reference standards for directly measured cardiorespiratory fitness and VO₂.
View updated FRIEND reference standards ↗ (opens in a new tab)Established clinical framework incorporating muscle strength, grip strength, chair-rise performance, muscle quantity, and physical function.
Read the EWGSOP2 consensus · 2019 ↗ (opens in a new tab)Functional mobility, balance, timed up-and-go testing, and fall-risk assessment in older adults.
View the official CDC STEADI resources ↗ (opens in a new tab)Bone Density & Fracture Resilience
Adult DXA interpretation, including appropriate use of T-scores and Z-scores according to age, sex, and menopausal status.
View the 2023 ISCD Official Adult Positions ↗ (opens in a new tab)Osteoporosis screening recommendations and evidence-based assessment of fracture-risk screening populations.
View the recommendation statement · 2025 ↗ (opens in a new tab)Function Beyond Biomarkers
A framework emphasizing locomotion, cognition, sensory capacity, psychological capacity, vitality, environmental support, and functional ability rather than disease status alone.
View the WHO healthy-ageing framework ↗ (opens in a new tab)Evidence-based guidance for identifying and managing declines in mobility, cognition, vitality and nutrition, sensory function, psychological capacity, and functional independence.
View the WHO ICOPE guidelines ↗ (opens in a new tab)Clinical guidelines, reference datasets, and healthy-aging evidence change over time. The methodology should be updated when important new guidance or stronger evidence becomes available.